Checkpoint Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate ...
In July 2024, Checkpoint announced that the FDA accepted for review the resubmission of its BLA for cosibelimab as a complete response to the complete response letter (“CRL”) issued in December 2023 ...
Tax Guru8 小时
EPFO Instructions on verification of Character & Antecedents on appointment
Employees Provident Fund Organisation (EPFO) issued instructions regarding the verification of character and antecedents for newly appointed employees, as per the guidelines of the Ministry of ...